Cargando…
Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients
BACKGROUND: Efavirenz (EFV) administration is still controversial for its high rates of interruption mainly related to central nervous system side effects (CNS-SE). Aim of the study was to define if single tablet regimen (STR) as compared to bis-in-die (BID) or once-daily (OD) with ≥2 pills-a-day EF...
Autores principales: | Fabbiani, Massimiliano, Zaccarelli, Mauro, Grima, Pierfrancesco, Prosperi, Mattia, Fanti, Iuri, Colafigli, Manuela, D’Avino, Alessandro, Mondi, Annalisa, Borghetti, Alberto, Fantoni, Massimo, Cauda, Roberto, Di Giambenedetto, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897945/ https://www.ncbi.nlm.nih.gov/pubmed/24418191 http://dx.doi.org/10.1186/1471-2334-14-26 |
Ejemplares similares
-
Single-tablet regimen is associated with reduced efavirenz withdrawal in antiretroviral naïve or switching for simplification HIV-infected patients
por: Fabbiani, M, et al.
Publicado: (2012) -
Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study
por: Prosperi, Mattia CF, et al.
Publicado: (2012) -
Liver fibrosis is associated with cognitive impairment in HIV-positive patients
por: Ciccarelli, Nicoletta, et al.
Publicado: (2014) -
Prevalence of osteoporosis and predictors of low BMD in a cohort of HIV-1-infected patients in Rome: features of a population at high risk
por: D'Avino, Alessandro, et al.
Publicado: (2014) -
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial
por: Fabbiani, Massimiliano, et al.
Publicado: (2014)